Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
about
Cartilage oligomeric matrix protein protects cells against death by elevating members of the IAP family of survival proteinsADAMTS-12 associates with and degrades cartilage oligomeric matrix proteinCartilage oligomeric matrix protein associates with granulin-epithelin precursor (GEP) and potentiates GEP-stimulated chondrocyte proliferationReview of Prospects of Biological Fluid Biomarkers in Osteoarthritis.Clinician's Commentary on Cupido et al.(1.).Evaluation of serum chondroitin sulfate and hyaluronan: biomarkers for osteoarthritis in canine hip dysplasia.Development and retranslational validation of an in vitro model to characterize acute infections in large human joints.Interaction between cartilage oligomeric matrix protein and extracellular matrix protein 1 mediates endochondral bone growth.Evaluation of the effect of salmon nasal proteoglycan on biomarkers for cartilage metabolism in individuals with knee joint discomfort: A randomized double-blind placebo-controlled clinical study.Relationship between synovial fluid ARGS-aggrecan fragments, cytokines, MMPs, and TIMPs following acute ACL injury: A cross-sectional study.High prevalence of knee osteoarthritis, pain, and functional limitations in female soccer players twelve years after anterior cruciate ligament injury.ADAMTS4 cleaves at the aggrecanase site (Glu373-Ala374) and secondarily at the matrix metalloproteinase site (Asn341-Phe342) in the aggrecan interglobular domain.Treatment of experimentally induced osteoarthritis in horses using an intravenous combination of sodium pentosan polysulfate, N-acetyl glucosamine, and sodium hyaluronan.Survey of the therapeutic approach and efficacy of pentosan polysulfate for the prevention and treatment of equine osteoarthritis in veterinary practice in Australia.ADAMTS-7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix proteinAssociation between synovial fluid levels of aggrecan ARGS fragments and radiographic progression in knee osteoarthritis.Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis.Ex vivo pathomechanics of the canine Pond-Nuki model.Soft tissue knee injury with concomitant osteochondral fracture is associated with higher degree of acute joint inflammation.Biomarkers of incident radiographic knee osteoarthritis: do they vary by chronic knee symptoms?Progranulin: a promising therapeutic target for rheumatoid arthritis.Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis.Extracellular matrix metabolites as potential biomarkers of disease activity in wound fluid: lessons learned from other inflammatory diseases?High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis.Ligament Injury, Reconstruction and Osteoarthritis.In vivo cartilage strain increases following medial meniscal tear and correlates with synovial fluid matrix metalloproteinase activity.Intraarticular Matrix Metalloproteinases and Aggrecan Degradation Are Elevated After Articular Fracture.Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dogEarly diagnosis to enable early treatment of pre-osteoarthritisXanthine oxidase injurious response in acute joint injuryCartilage markers and their association with cartilage loss on magnetic resonance imaging in knee osteoarthritis: the Boston Osteoarthritis Knee Study.Gait patterns differ between ACL-reconstructed athletes who pass return-to-sport criteria and those who fail.Serum protein signatures detect early radiographic osteoarthritis.Inflammatory mediators and cartilage biomarkers in synovial fluid after a single inflammatory insult: a longitudinal experimental studyFully automatic analysis of the knee articular cartilage T1ρ relaxation time using voxel-based relaxometry.Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study.The complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritis.The emerging roles of ADAMTS-7 and ADAMTS-12 matrix metalloproteinases.Decreased lubricin concentrations and markers of joint inflammation in the synovial fluid of patients with anterior cruciate ligament injury.
P2860
Q24300020-42264DD8-11DB-42B8-B2D5-4DCBA791B8A6Q24317122-3720AF4C-56D7-4782-B044-4C9AEB8FF9AEQ28569341-131DF42D-4E82-42C7-A369-D1329F995C05Q30359055-F7E35750-7218-4D08-ACBC-014284A7CDA9Q33551680-D2636E98-C02B-4CAC-97DF-285C9A778E44Q33612450-93A9FF78-F1E0-4E24-92C4-9D17DD4D23A4Q33615549-1646A152-AB74-48A0-8179-CFCD0024A3EDQ33823788-2746A67B-F909-4878-8181-DD9B1FD4FDE3Q33847208-A34FD2E9-C71C-4E10-AE82-E2E19FAA801FQ33900824-600BC94C-6C72-4AC2-A708-CEA4BFE990E1Q33982261-3FB63030-2E4E-4135-B5A2-98176D2CE8EAQ34114956-8A023C87-6F99-48EC-975B-A7F1A696F113Q34419665-732DC5FC-4223-4AD4-8958-471B57775D21Q34449528-78B8FBD2-5DBD-44A8-9EF9-6DE04C13E560Q34508676-BCF0C739-2248-4823-8E55-027BB194B8B5Q34614109-FBA808FE-A42E-4065-80F3-EFD08EF307F2Q34896346-916B75BF-09B5-4578-A0A1-9520563941D1Q35069560-DEC31775-014D-441F-9DFB-2CFDBC0E9067Q35130236-A94D6B59-A69C-40DF-933E-36090D63805FQ35146138-B18AB8E7-D94E-45A0-8CD5-D379E386E386Q35182029-70AC8EAC-AE2D-4D5E-9426-F318BC8714F4Q35550507-13038945-9B8B-4F97-8F5F-94F48ED0FD4BQ35555490-31CEB56D-A815-4165-AA29-2C1B7610F599Q35696629-423E2465-1B26-41AB-9768-F9C738C210BBQ35869021-1965C8CC-6311-4E69-8106-D0C9A620B528Q35941025-4CA41783-EA28-49B3-84F5-399882CAD927Q36021104-372780CA-DFCE-49D6-A913-D4F73BC055DBQ36037778-694B05BF-1942-4618-9E31-980488582844Q36102860-CD0C6BDD-3BDB-4F7C-B888-859D1C3FAE28Q36245995-29232341-AB3C-4547-8C23-10A3A53CB98FQ36307648-CF986BDB-7478-4D79-A007-9F62816861DBQ36401945-240FE998-B498-4509-9E45-82103EA60DC8Q37067003-4A80CE7B-8BAE-4FC7-B546-08213C8422B3Q37154116-C884A921-6BA9-4A97-9311-E220DD7B6D55Q37206899-57D8359E-C181-4663-9498-DAA49D57673EQ37246249-98B3E0DB-3949-4C55-9964-928F2C525FC8Q37270865-68E1D2BC-9EFA-4D93-934A-DBE6290973D4Q37315643-01229EE9-70CB-4DA5-976A-6F15CFF73B1AQ37358106-42FAB971-9783-4E91-9191-83EA83F6A162Q37464064-B0F2140F-03A4-48A6-BE9C-D55EAC8AB5DE
P2860
Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
@en
Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
@nl
type
label
Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
@en
Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
@nl
prefLabel
Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
@en
Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
@nl
P2093
P2860
P1476
Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
@en
P2093
P2860
P304
P356
10.1002/1529-0131(199904)42:3<534::AID-ANR19>3.0.CO;2-J
P577
1999-03-01T00:00:00Z